Investigation of the Effects of Dual Task Training on Dual Task Performance in Individuals With Scoliosis
NCT06817538, Not applicable, Completed, Hacettepe University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Investigation of the Effects of Dual Task Training on Dual Task Performance in Individuals With Scoliosis | ClinicalTrials.gov |
| NCT number | NCT06817538 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 38 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Hacettepe University | ClinicalTrials.gov |
| Conditions | Idiopathic Scoliosis | ClinicalTrials.gov |
| Interventions | Physiotherapy/Exercise Program | ClinicalTrials.gov |
| First posted | 2025-02-10 | ClinicalTrials.gov |
| Last updated | 2025-04-15 | ClinicalTrials.gov |
Registered outcomes 8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Single Motor - Cadence | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week) | 10 meter walking test. Measurements will begin with the participant's first step from the starting line and will end as they cross the finish line. Each participant will complete three trials, during which the step count and duration will be recorded. Based on these evaluations cadence (steps/min) will be calculated. | ClinicalTrials.gov |
| Primary | Single Motor - Step Lengths | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week) | 10 meter walking test. Measurements will begin with the participant's first step from the starting line and will end as they cross the finish line. Each participant will complete three trials, during which the step count and duration will be recorded. Based on these evaluations step lengths (m) will be calculated. | ClinicalTrials.gov |
| Primary | Single Motor - Walking Speed | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week) | 10 meter walking test. Measurements will begin with the participant's first step from the starting line and will end as they cross the finish line. Each participant will complete three trials, during which the step count and duration will be recorded. Based on these evaluations, walking speed (m/min) will be calculated. | ClinicalTrials.gov |
| Primary | Single Cognitive | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week) | Stroop Test | ClinicalTrials.gov |
| Primary | Dual-Task ( Number) | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week). | Giving specific cognitive tasks during a 10m walk. These cognitive tasks will be counting backwards in 7's from a random number between 50-100. | ClinicalTrials.gov |
| Primary | Dual-Task (Letter) | From baseline assessment to post-intervention at 12 weeks (after 12 exercise sessions, one session per week). | Participants will read a 5-letter word backward during a 10-meter walk. Each word will be provided randomly, and participants will be instructed to articulate the letters of the word in reverse order while walking. | ClinicalTrials.gov |
| Secondary | Body Asymmetry and Posture Assessments | Baseline measurements conducted at the initial assessment. Participants will undergo a 12-week exercise intervention, with one session per week. Post-treatment assessments will be conducted immediately after completing the 12 sessions at the 12th week. | Anterior and Posterior Trunk Symmetry Index | ClinicalTrials.gov |
| Secondary | Scoliosis-specific assessments 2 | Baseline measurements conducted at the initial assessment. Participants will undergo a 12-week exercise intervention, with one session per week. Post-treatment assessments will be conducted immediately after completing the 12 sessions at the 12th week. | Anterior Trunk Rotation. The ATR is measured with the help of a scoliometer (inclinometer), a scoliosis measuring device, which evaluates the rotation of the trunk in degrees with the patient in a forward-bent position (Adam's Test position) | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)